GGrantIndex
← Leaderboards

Namita Rout

Tulane University Of Louisiana

$7,643,352
Attributed
$7,920,734
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY201725
$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,920,734 · 8

By mechanism

R01$2,868,592 · 1
P20$1,537,376 · 2
R33$1,506,213 · 1
R21$1,453,789 · 3
R56$554,764 · 1

Top collaborators

Most similar at Tulane University Of Louisiana

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Macaca

Research focus

MacacaInfectionCellsT-LymphocyteCytokineHiv InfectionsViralAntiretroviral TherapyMucous MembranePreventMicrobialImmuneIn VivoBaseIn VitroMacaca MulattaPersonsInflammationî³î´ T CellsGut MucosaFunctional DisorderSimian Human Immunodeficiency VirusCell PhysiologyBiopsy

Grant awards (20)

Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation$721,380
R01 · FY2025 · DK · contact PI
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation$706,304
R01 · FY2024 · DK · contact PI
Development of Gamma delta CAR-T cells to target CNS HIV reservoir$222,084
R21 · FY2024 · MH · contact PI
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation$724,920
R01 · FY2023 · DK · contact PI
Development of Gamma delta CAR-T cells to target CNS HIV reservoir$284,584
R21 · FY2023 · MH · contact PI
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation$715,988
R01 · FY2022 · DK · contact PI
Innate immune mechanisms of epithelial barrier disruption during treated HIV and SIV infections$554,764
R56 · FY2022 · DK · contact PI
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs$494,712
R33 · FY2022 · AI · contact PI
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs$502,807
R33 · FY2021 · AI · contact PI
Role of Innate Immunity and Microbiome in the Inflammation of Aging and Long-Term Antiretroviral Therapy$131,942
P20 · FY2021 · GM · contact PI
Role of Innate Immunity and Microbiome in the Inflammation of Aging and Long-Term Antiretroviral Therapy$131,940
P20 · FY2021 · GM · contact PI
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs$508,694
R33 · FY2020 · AI · contact PI
Role of Innate Immunity and Microbiome in the Inflammation of Aging and Long-Term Antiretroviral Therapy$302,596
P20 · FY2020 · GM · contact PI
Role of Innate Immunity and Microbiome in the Inflammation of Aging and Long-Term Antiretroviral Therapy$353,845
P20 · FY2019 · GM · contact PI
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs$229,238
R21 · FY2019 · AI · contact PI
Role of Lipid Antigen-Specific T Cells in the Anti-mycobacterial Immune Response of BCG/SIV Infected Macaques$212,500
R21 · FY2019 · AI · contact PI
Role of Innate Immunity and Microbiome in the Inflammation of Aging and Long-Term Antiretroviral Therapy$318,560
P20 · FY2018 · GM · contact PI
Role of Lipid Antigen-Specific T Cells in the Anti-mycobacterial Immune Response of BCG/SIV Infected Macaques$274,455
R21 · FY2018 · AI · contact PI
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs$230,928
R21 · FY2018 · AI · contact PI
Role of Innate Immunity and Microbiome in the Inflammation of Aging and Long-Term Antiretroviral Therapy$298,493
P20 · FY2017 · GM · contact PI